Algert Global’s Regenxbio RGNX Stock Holding History

Algert Global’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492K	Buy	41,060 +17,160	+72%	+$142K	0.01%	1074
2026 Q1	$200K	Buy	+23,900	New	+$251K	﹤0.01%	1079
2025 Q4	–	Sell	-10,040	Closed	-$96.9K	–	1291
2025 Q3	$96.9K	Sell	10,040 -10,208	-50%	-$90.3K	﹤0.01%	1087
2025 Q2	$166K	Sell	20,248 -29,330	-59%	-$246K	﹤0.01%	1105
2025 Q1	$354K	Buy	+49,578	New	+$369K	0.01%	979
2024 Q1	–	Sell	-17,990	Closed	-$323K	–	1239
2023 Q4	$323K	Buy	+17,990	New	+$317K	0.01%	921
2022 Q2	–	Sell	-11,073	Closed	-$368K	–	1351
2022 Q1	$368K	Buy	+11,073	New	+$308K	0.02%	912
2021 Q1	–	Sell	-30,124	Closed	-$1.37M	–	512
2020 Q4	$1.37M	Buy	30,124 +11,343	+60%	+$396K	0.39%	86
2020 Q3	$517K	Buy	+18,781	New	+$612K	0.16%	187

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Algert Global's RGNX Position: Q2 2026 in Review

Algert Global increased its Regenxbio (RGNX) stake by 72% in Q2 2026, buying an estimated $142K and bringing the position to 41,060 shares worth $492K. The position accounts for 0.01% of the portfolio, ranked #1074.

Algert Global first reported a position in RGNX in Q3 2020 and has held it in 9 quarters since. The position peaked at $1.37M in Q4 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

Algert Global held 41,060 shares of Regenxbio worth $492K as of Q2 2026.
Algert Global bought 17,160 Regenxbio shares in Q2 2026, an estimated $142K.
Regenxbio made up 0.01% of Algert Global's portfolio in Q2 2026, its #1074 holding.
Algert Global first reported a position in Regenxbio in Q3 2020 and has held it in 9 quarters since.
Algert Global's Regenxbio position peaked at $1.37M in Q4 2020.
165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.